D Molecular Therapeutics reported its experimental gene therapy demonstrated a nearly 90% reduction in the need for ...

New Biological Data Released from IRO® Cell Therapy Manufacturing Platform The IRO platform The IRO up close IRO Interior ...

Just a few months after the reveal of Ori Biotech’s automated cell and gene therapy manufacturing platform IRO, the technical ...

New Novartis data in relapsing MS reinforce benefits of Kesimpta for first-line and switch patients: Basel Friday, September 20, 2024, 12:00 Hrs [IST] Novartis announced new data ...

Having already scooped up the U.S. rights to Capricor Therapeutics’ late-stage Duchenne muscular dystrophy (DMD) therapy, ...

For contract manufacturers, deciding whether to invest—or not—in innovative technologies can be even more complicated ...

Debanjana Chatterjee, an analyst from JonesTrading, has initiated a new Buy rating on Intellia Therapeutics (NTLA). Debanjana ...

Following Miami Dolphins quarterback Tua Tagovailoa's latest concussion, top Florida neurologists are encouraging the use of hyperbaric oxygen therapy.

Immunosuppressants used in adeno-associated virus (AAV) gene therapy for monogenic disorders present an adverse effect ...

A team of researchers report findings from a Phase I/II gene therapy clinical trial for patients with Leber congenital ...

Shares dropped by as much as one-quarter Thursday after the biotech shared longer-term results for a gene therapy it’s developing for wet AMD.

if the potential benefits of gene therapy or other targeted treatments for hereditary retinal and optic nerve disorders are to be offered to affected patients. To take advantage in full of these ...